AutoZone To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Tuesday
Avi Kapoor 7 months ago
Analysts change outlook on top names: Truist cut KFY price target, Oppenheimer raised AZO target, B. Riley slashed YEXT target, Stifel cut MTN target, RBC raised KNTK target, Truist cut MAA target, Wells Fargo raised XENE target, Citigroup raised HIMS target.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- Truist Securities cut Korn Ferry (NYSE:KFY) price target from $88 to $75. Truist Securities analyst Tobey Sommer maintained a Buy rating. Korn Ferry shares closed at $62.63 on Monday. See how other analysts view this stock.
- Oppenheimer raised the price target for AutoZone Inc (NYSE:AZO) from $4,150 to $4,300. Oppenheimer analyst Brian Nagel reiterated an Outperform rating. AutoZone shares closed at $3,672.68 on Monday. See how other analysts view this stock.
- B. Riley Securities slashed Yext, Inc. (NYSE:YEXT) price target from $10 to $8. B. Riley Securities analyst Naved Khan maintained a Buy rating. Yext shares closed at $5.64 on Monday. See how other analysts view this stock.
- Stifel cut the price target for Vail Resorts, Inc. (NYSE:MTN) from $175 to $172. Stifel analyst Jeffrey Stantial maintained a Buy rating. Vail Resorts shares closed at $133.94 on Monday. See how other analysts view this stock.
- RBC Capital raised the price target for Kinetik Holdings Inc. (NYSE:KNTK) from $46 to $49. RBC Capital analyst Elvira Scotto maintained an Outperform rating. Kinetik shares closed at $45.37 on Monday. See how other analysts view this stock.
- Truist Securities cut Mid-America Apartment Communities, Inc. (NYSE:MAA) price target from $146 to $142. Truist Securities analyst Michael Lewis maintained a Buy rating. Mid-America Apartment shares closed at $132.14 on Monday. See how other analysts view this stock.
- Wells Fargo increased Xenon Pharmaceuticals Inc. (NASDAQ:XENE) price target from $49 to $68. Wells Fargo analyst Benjamin Burnett maintained an Overweight rating. Xenon Pharmaceuticals shares closed at $62.76 on Monday. See how other analysts view this stock.
- Citigroup raised Hims & Hers Health, Inc. (NYSE:HIMS) price target from $13.25 to $24. Citigroup analyst Daniel Grosslight upgraded the stock from Sell to Neutral. Hims & Hers Health shares closed at $22.16 on Monday. See how other analysts view this stock.
- Wedbush raised the price target for Dianthus Therapeutics, Inc. (NASDAQ:DNTH) from $55 to $80. Wedbush analyst Laura Chico maintained an Outperform rating. Dianthus Therapeutics shares closed at $79.23 on Monday. See how other analysts view this stock.
- B of A Securities cut The Progressive Corporation (NYSE:PGR) price target from $315 to $308. B of A Securities analyst Joshua Shanker maintained a Buy rating. Progressive shares closed at $206.80 on Monday. See how other analysts view this stock.
Considering buying AZO stock? Here’s what analysts think:
Photo via Shutterstock